ATXI — Avenue Therapeutics Share News
0.000.00%
- $1.27m
- -$0.67m
- $1.40m
Brief: Avenue Therapeutics Says CEO To Resign
Brief: Avenue Therapeutics ReceiveS Appeal Denied Letter From FDA In Response To Its Formal Dispute Resolution Request Submitted In Aug 2021
Brief: Avenue Therapeutics Says Exploring A Range Of Strategic Transaction Options For Co
NASDAQ RESUMED AT 11:10 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 11:07 AM
NASDAQ RESUMED AT 10:14 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 10:09 AM
NASDAQ RESUMED AT 10:06 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 10:01 AM
NASDAQ RESUMED AT 09:58 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:52 AM
U.S. STOCKS ON THE MOVE-Avenue Therapeutics, Shopify, Wynn Resorts, Digital World Acquisition Corp
Avenue Therapeutics feels the sting as FDA panel votes against painkiller
NASDAQ RESUMED AT 07:10 AM
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM
Brief: Avenue Therapeutics Says Nasdaq Halted Trading Of Company's Common Stock
NASDAQ TRADE HALT HALT NEWS PENDING AT 06:55 AM
Brief: Avenue Therapeutics Says Joseph Vazzano Resigning From His Role As CFO
U.S. STOCKS ON THE MOVE-Peloton, Novavax, Coca-Cola, Arena Pharma